Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Mondino

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Immunology Letters|March 26, 2005
Immune surveillance and anti-tumor immune responses: an anatomical perspectiveValerie S Zimmermann, Fabio Benigni, Anna Mondino
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Clonal anergy is maintained independently of T cell proliferationSara Colombetti, Fabio Benigni, Veronica Basso, et al.
Plos One|June 19, 2008
Cytosolic sequestration of Prep1 influences early stages of T cell developmentDmitry Penkov, Martina Palazzolo, Anna Mondino, et al.
Plos One|March 18, 2014
Monoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individualsKarolina Pilipow, Veronica Basso, Nicola Migone, et al.
Plos One|June 8, 2019
Correction: Monoallelic Germline TSC1 Mutations Are Permissive for T Lymphocyte Development and Homeostasis in Tuberous Sclerosis Complex IndividualsKarolina Pilipow, Veronica Basso, Nicola Migone, et al.
European Journal of Immunology|December 2, 2009
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cellsStefano Caserta, Patrizia Alessi, Veronica Basso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2010
Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigensStefano Caserta, Joanna Kleczkowska, Anna Mondino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycinSara Colombetti, Veronica Basso, Daniel L Mueller, et al.
Cancer Research|April 17, 2008
Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responsesStefano Caserta, Patrizia Alessi, Jlenia Guarnerio, et al.
Cancer Research|July 16, 2010
Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivoChris Schiering, Jlenia Guarnerio, Veronica Basso, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Immunology Letters|March 26, 2005
Immune surveillance and anti-tumor immune responses: an anatomical perspectiveValerie S Zimmermann, Fabio Benigni, Anna Mondino
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Clonal anergy is maintained independently of T cell proliferationSara Colombetti, Fabio Benigni, Veronica Basso, et al.
Plos One|June 19, 2008
Cytosolic sequestration of Prep1 influences early stages of T cell developmentDmitry Penkov, Martina Palazzolo, Anna Mondino, et al.
Plos One|March 18, 2014
Monoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individualsKarolina Pilipow, Veronica Basso, Nicola Migone, et al.
Plos One|June 8, 2019
Correction: Monoallelic Germline TSC1 Mutations Are Permissive for T Lymphocyte Development and Homeostasis in Tuberous Sclerosis Complex IndividualsKarolina Pilipow, Veronica Basso, Nicola Migone, et al.
European Journal of Immunology|December 2, 2009
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4(+) T cellsStefano Caserta, Patrizia Alessi, Veronica Basso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2010
Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigensStefano Caserta, Joanna Kleczkowska, Anna Mondino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycinSara Colombetti, Veronica Basso, Daniel L Mueller, et al.
Cancer Research|April 17, 2008
Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responsesStefano Caserta, Patrizia Alessi, Jlenia Guarnerio, et al.
Cancer Research|July 16, 2010
Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivoChris Schiering, Jlenia Guarnerio, Veronica Basso, et al.
Pageof 9